Stay updated on Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.

Latest updates to the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. This appears to be a backend content management update with no changes to the study information.SummaryDifference0.0%

- Check21 days agoChange DetectedThe publications section text was clarified to indicate auto-fill from PubMed and that articles may not be about the study. The footer revision tag was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded Tainan, Taiwan as a study site and removed the listing for Tainan City, Taiwan. The banner with government funding status was deleted.SummaryDifference0.3%

- Check43 days agoChange DetectedCore study details including title, conditions, design, enrollment, and outcome measures appear unchanged between screenshots. The observed differences are limited to layout/formatting and do not modify the underlying data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedUpdate includes a government funding operations notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check79 days agoChange Detected- Updated the revision from v3.0.2 to v3.1.0, indicating a new software version. No other substantive content changes are evident.SummaryDifference0.1%

Stay in the know with updates to Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.